Information Provided By:
Fly News Breaks for July 22, 2015
PRTA
Jul 22, 2015 | 07:39 EDT
After meeting with investors and Prothena's management, RBC Capital believes that investors are becoming more aware of the company's long-term potential. The firm thinks that investors are realizing that the company has several drugs with significant long-term potential. It believes that the company has a number of positive catalysts that should enable the stock to continue to climb. RBC keeps an Outperform rating on the shares.
News For PRTA From the Last 2 Days
There are no results for your query PRTA
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.